Invitae Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies Panel
Use
The Invitae Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies Panel analyzes genes associated with thrombotic microangiopathies, including atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. These conditions are characterized by hemolytic anemia, thrombocytopenia, and kidney damage which may progress to kidney failure.
Special Instructions
Invitae is a CAP-accredited and CLIA-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using NGS technology. Our sequence analysis covers clinically important regions of each gene.
Limitations
Limitations include reduced sensitivity for insertions and deletions larger than 15bp but smaller than a full exon, and potential non-detection of certain structural rearrangements, complex sequence variants, and single-exon events. Sequence changes in non-coding assays are not guaranteed unless explicitly stated.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
10-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3mL
Minimum Volume
Not provided
Container
purple-top EDTA tube (K2EDTA or K3EDTA)